To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ANKRD35andPIAS3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
561 representative clones for gene ANKRD35andPIAS3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_144698.3   .a 1 to 3362 2 to 3363 exact RefSeq,   3363/3363
(100 %)
0 diff
(100 %id)
DC422796 uterus .a 1 to 461 2 to 462       462/462
(100 %)
1 diff
(99.8 %id)
DA399526 thalamus .a 1 to 552 2 to 553   tiling clone, capped   552/552
(100 %)
0 diff
(100 %id)
DA451283 tongue, tumor tissue .a 8 to 561 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA455710 tongue, tumor tissue .a 15 to 580 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA433594 tongue, tumor tissue .a 22 to 564 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DA218364 brain .a 29 to 554 2 to 528   capped   527/527
(100 %)
1 diff
(99.9 %id)
AK091120 tongue, tumor tissue .a 35 to 3357 1 to 3323 S188A P428S E820G available from FLJ,   3323/3323
(100 %)
7 diff
(99.8 %id)
AX746788   .a 35 to 3357 1 to 3323 S188A P428S E820G     3323/3323
(100 %)
7 diff
(99.8 %id)
DA434166 tongue, tumor tissue .a 36 to 558 2 to 524   capped   523/523
(100 %)
0 diff
(100 %id)
DA443917 tongue, tumor tissue .a 36 to 620 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
DA461715 tongue, tumor tissue .a 36 to 597 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA856491 placenta .a 36 to 600 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DB226463 trachea .a 36 to 593 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BC101618 Lung and heart, PCR rescued clones .a 53 to 3135 1 to 3083 P428S tiling clone,   3083/3083
(100 %)
2 diff
(100.0 %id)
BC101620 Lung and heart, PCR rescued clones .a 53 to 3135 1 to 3083 P428S     3083/3083
(100 %)
2 diff
(100.0 %id)
TI_927043475   .a 53 to 1145 45 to 1136       1092/1224
(89 %)
22 diff
(98.3 %id)
TI_927043481   .a 53 to 1185 47 to 1176       1130/1227
(92 %)
30 diff
(97.6 %id)
TI_927043488   .a 53 to 1212 60 to 1222     Submitted on the opposite strand 1163/1246
(93 %)
27 diff
(97.9 %id)
TI_927043494   .a 53 to 1215 58 to 1212     Submitted on the opposite strand 1155/1225
(94 %)
32 diff
(97.4 %id)
TI_927045678   .a 53 to 957 913 to 7       907/1244
(72 %)
4 diff
(99.7 %id)
TI_927046929   .a 53 to 561 548 to 40       509/925
(55 %)
0 diff
(100 %id)
TI_927046304   .a 277 to 1399 1130 to 2       1129/1168
(96 %)
23 diff
(98.1 %id)
TI_927046300   .a 280 to 1398 1120 to 2       1119/1262
(88 %)
9 diff
(99.3 %id)
TI_927046928   .a 280 to 1392 1113 to 3       1111/1257
(88 %)
4 diff
(99.7 %id)
TI_927044393   .a 432 to 1525 1 to 1094       1094/1204
(90 %)
14 diff
(98.9 %id)
BF829251 head_normal .a 522 to 1109 1 to 587       587/587
(100 %)
5 diff
(99.2 %id)
BF829534 head_normal .a 523 to 1110 1 to 589       589/589
(100 %)
25 diff
(95.8 %id)
TI_927046932   .a 595 to 1399 808 to 4       805/808
(99 %)
2 diff
(99.8 %id)
TI_927046927   .a 625 to 1774 1162 to 8       1155/1230
(93 %)
25 diff
(98.0 %id)
TI_927046299   .a 664 to 1797 1132 to 2       1131/1275
(88 %)
9 diff
(99.3 %id)
TI_927046303   .a 835 to 1796 965 to 4       962/965
(99 %)
3 diff
(99.7 %id)
TI_927046926   .a 1006 to 2216 1220 to 5       1216/1268
(95 %)
0 diff
(100 %id)
TI_927046931   .a 1187 to 1763 599 to 23       577/599
(96 %)
0 diff
(100 %id)
TI_927046298   .a 1190 to 2216 1038 to 12       1027/1297
(79 %)
0 diff
(100 %id)
TI_927046302   .a 1223 to 2216 1016 to 14       1003/1016
(98 %)
0 diff
(100 %id)
AW245831 lung, small cell carcinoma .a 1305 to 1785 9 to 489   tiling clone,   481/489
(98 %)
0 diff
(100 %id)
TI_927046930   .a 1383 to 2216 845 to 6       840/845
(99 %)
0 diff
(100 %id)
AW273207 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 1392 to 1851 460 to 1       460/460
(100 %)
0 diff
(100 %id)
BE796869 lung, small cell carcinoma .a 1426 to 2202 1 to 768       768/985
(77 %)
10 diff
(99.0 %id)
TI_927045677   .a 1510 to 2670 1172 to 6       1167/1172
(99 %)
0 diff
(100 %id)
TI_927045673   .a 1537 to 2673 1132 to 3       1130/1240
(91 %)
0 diff
(100 %id)
TI_927045676   .a 1867 to 2985 1156 to 35       1122/1157
(96 %)
19 diff
(98.4 %id)
TI_927045672   .a 1871 to 2985 1135 to 32       1104/1240
(89 %)
12 diff
(99.1 %id)
BG698935 skin .a 1902 to 2702 1 to 804       804/804
(100 %)
13 diff
(98.4 %id)
TI_154000739   .a 1937 to 2468 134 to 671   AAA Submitted on the opposite strand 538/1157
(46 %)
6 diff
(99.5 %id)
TI_927043476   .a 1940 to 3135 1238 to 54     Submitted on the opposite strand 1185/1253
(94 %)
17 diff
(98.7 %id)
TI_927043493   .a 1979 to 3143 1223 to 59       1165/1235
(94 %)
28 diff
(97.8 %id)
TI_927043487   .a 2000 to 3143 1192 to 57       1136/1213
(93 %)
30 diff
(97.6 %id)
DA965573 stomach .a 2028 to 2589 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
CN295218 embryonic stem cells, cell lines H1, H7, andH9 .a 2035 to 2685 12 to 663       652/663
(98 %)
5 diff
(99.3 %id)
TI_927043482   .a 2093 to 3135 1092 to 56     Submitted on the opposite strand 1037/1221
(84 %)
13 diff
(99.0 %id)
BI827661 brain, medulla .a 2106 to 2869 1 to 768       768/768
(100 %)
8 diff
(99.0 %id)
TI_57172041   .a 2106 to 2869 29 to 796       768/796
(96 %)
6 diff
(99.3 %id)
AK057853 brain .a 2110 to 3362 1 to 1253   tiling clone, available from FLJ,   1253/1253
(100 %)
1 diff
(100.0 %id)
BP213244 cerebrum .a 2110 to 2687 1 to 578       578/578
(100 %)
1 diff
(99.9 %id)
DB636595 hypothalamus .a 2110 to 2793 1 to 684       684/684
(100 %)
4 diff
(99.5 %id)
DB636622 hypothalamus .a 2110 to 2838 1 to 728       728/728
(100 %)
9 diff
(98.8 %id)
BQ636616 eye, retina .a 2130 to 2761 1 to 632       632/632
(100 %)
0 diff
(100 %id)
CR621087 Placenta Cot 25-normalized .a 2134 to 3329 1 to 1196   tiling clone,   1196/1196
(100 %)
0 diff
(100 %id)
BX359417 Placenta Cot 25-normalized .a 2134 to 3015 1 to 883   fully sequenced,   883/883
(100 %)
5 diff
(99.5 %id)
DT217144 brain .a 2135 to 2731 1 to 597       597/597
(100 %)
4 diff
(99.4 %id)
BQ638805 eye, retina .a 2142 to 2769 10 to 637       628/637
(98 %)
8 diff
(98.8 %id)
DA109426 cerebellum .a 2262 to 2844 2 to 585   capped   584/584
(100 %)
2 diff
(99.7 %id)
BX381493 Placenta Cot 25-normalized .a 2290 to 3322 1032 to 1       1032/1072
(96 %)
31 diff
(97.2 %id)
TI_154055657   .a 2463 to 3357 972 to 88   AAA   885/1011
(87 %)
33 diff
(96.8 %id)
BQ009216 Chondrosarcoma, Left Pubic Bone .a 2591 to 3357 785 to 19   AAA   767/767
(100 %)
3 diff
(99.7 %id)
TI_149312762   .a 2608 to 3357 833 to 84   AAA   750/988
(75 %)
2 diff
(99.8 %id)
BM978311 lung .a 2608 to 3357 768 to 19   AAA   750/750
(100 %)
2 diff
(99.8 %id)
DB560460 hypothalamus .a 2638 to 3362 1 to 721     Submitted on the opposite strand 721/721
(100 %)
13 diff
(98.2 %id)
TI_149294340   .a 2677 to 3357 763 to 83   AAA   681/682
(99 %)
0 diff
(100 %id)
TI_149289923   .a 2696 to 3357 774 to 114   AAA   661/661
(100 %)
1 diff
(99.9 %id)
BU683120 lung .a 2697 to 3357 679 to 19   AAA   661/661
(100 %)
0 diff
(100 %id)
DB567968 hypothalamus .a 2725 to 3362 1 to 637     Submitted on the opposite strand 637/637
(100 %)
14 diff
(97.9 %id)
BM973074 lung .a 2756 to 3357 620 to 19   AAA   602/602
(100 %)
0 diff
(100 %id)
DB313285 tongue, tumor tissue .a 2803 to 3357 555 to 1       555/556
(99 %)
1 diff
(99.9 %id)
BM700206 eye, lens .a 2806 to 3081 1 to 276   fully sequenced,   276/276
(100 %)
0 diff
(100 %id)
TI_154004533   .a 2810 to 3357 667 to 120   AAA   548/549
(99 %)
2 diff
(99.7 %id)
DB334512 stomach .a 2819 to 3357 539 to 1       539/539
(100 %)
0 diff
(100 %id)
BM987645 mixed .a 2827 to 3357 549 to 19   AAA   531/531
(100 %)
0 diff
(100 %id)
AW511401 pooled germ cell tumors .a 2832 to 3353 531 to 10       522/531
(98 %)
0 diff
(100 %id)
AI621064 pooled germ cell tumors .a 2847 to 3362 516 to 1       516/516
(100 %)
0 diff
(100 %id)
AI653380 pooled germ cell tumors .a 2847 to 3358 517 to 6       512/517
(99 %)
0 diff
(100 %id)
AI953151 pooled germ cell tumors .a 2872 to 3361 490 to 1       490/490
(100 %)
0 diff
(100 %id)
BF920851 nervous_tumor .a 2877 to 3331 23 to 477       455/477
(95 %)
8 diff
(98.4 %id)
CA433679 mixed .a 2893 to 3357 483 to 19   AAA   465/465
(100 %)
1 diff
(99.8 %id)
CU445679 epidermis .a 2901 to 3354 456 to 3     Submitted on the opposite strand 454/477
(95 %)
1 diff
(99.8 %id)
CA427060 Bone, Subchondral Bone .a 2931 to 3357 445 to 19   AAA   427/427
(100 %)
1 diff
(99.8 %id)
AI968473 pooled germ cell tumors .a 2942 to 3362 421 to 1       421/421
(100 %)
0 diff
(100 %id)
BX359416 Placenta Cot 25-normalized .a 2954 to 3329 378 to 1   fully sequenced,   378/378
(100 %)
3 diff
(99.3 %id)
CU445710 epidermis .a 2967 to 3354 390 to 3     Submitted on the opposite strand 388/397
(97 %)
3 diff
(99.3 %id)
CU451377 epidermis .a 2967 to 3354 390 to 3     Submitted on the opposite strand 388/397
(97 %)
3 diff
(99.3 %id)
CU450707 epidermis .a 2971 to 3354 386 to 3     Submitted on the opposite strand 384/397
(96 %)
1 diff
(99.8 %id)
CU447293 epidermis .a 2982 to 3354 375 to 3     Submitted on the opposite strand 373/400
(93 %)
1 diff
(99.8 %id)
BF350190 head_neck .a 2984 to 3242 303 to 44       260/318
(81 %)
1 diff
(99.7 %id)
AW590824 pooled germ cell tumors .a 2986 to 3358 373 to 1       373/373
(100 %)
3 diff
(99.2 %id)
BF340352 brain, glioblastoma with EGFR amplification .a 2992 to 3362 1 to 371       371/400
(92 %)
1 diff
(99.8 %id)
TI_149275282   .a 2992 to 3357 447 to 82   AAA   366/554
(66 %)
0 diff
(100 %id)
BM968698 lung, Primary Lung Epithelial Cells .a 2992 to 3357 384 to 19   AAA   366/374
(97 %)
0 diff
(100 %id)
BU737924 eye, lens .a 3020 to 3357 357 to 20   fully sequenced, AAA   338/338
(100 %)
1 diff
(99.8 %id)
CU446893 epidermis .a 3024 to 3354 333 to 3     Submitted on the opposite strand 331/354
(93 %)
0 diff
(100 %id)
CU446902 epidermis .a 3024 to 3354 333 to 3     Submitted on the opposite strand 331/354
(93 %)
1 diff
(99.8 %id)
AA928325 pooled germ cell tumors .a 3029 to 3362 334 to 1       334/334
(100 %)
1 diff
(99.8 %id)
AI634073 pooled germ cell tumors .a 3031 to 3358 328 to 1       328/328
(100 %)
2 diff
(99.4 %id)
AI631618 pooled germ cell tumors .a 3035 to 3358 324 to 1       324/324
(100 %)
2 diff
(99.4 %id)
BX096102 esophagus, squamous cell carcinoma .a 3036 to 3357 336 to 15   AAA   322/324
(99 %)
2 diff
(99.4 %id)
AI969067 pooled germ cell tumors .a 3042 to 3362 321 to 1       321/321
(100 %)
0 diff
(100 %id)
CU444400 epidermis .a 3070 to 3354 287 to 3     Submitted on the opposite strand 285/318
(89 %)
0 diff
(100 %id)
CU455147 epidermis .a 3070 to 3354 287 to 3     Submitted on the opposite strand 285/308
(92 %)
0 diff
(100 %id)
EL593317 epidermis, skin .a 3070 to 3361 46 to 337       292/338
(86 %)
15 diff
(95.6 %id)
AI354869 esophagus, squamous cell carcinoma .a 3078 to 3357 296 to 17   AAA   280/280
(100 %)
4 diff
(98.6 %id)
F36201 pectoral muscle (after mastectomy) .a 3082 to 3198 1 to 118       118/127
(92 %)
1 diff
(99.3 %id)
CU445198 epidermis .a 3095 to 3354 263 to 3     Submitted on the opposite strand 261/279
(93 %)
4 diff
(98.6 %id)
CU451237 epidermis .a 3095 to 3354 263 to 3     Submitted on the opposite strand 261/279
(93 %)
4 diff
(98.6 %id)
DB244724 uterus, tumor tissue .b 1 to 557 9 to 565   capped   564/564
(100 %)
5 diff
(99.2 %id)
NM_006099.3   .b 1 to 2896 7 to 2902 exact RefSeq,   2902/2902
(100 %)
2 diff
(100.0 %id)
AK027557   .b 1 to 2896 6 to 2901 L247P tiling clone, available from FLJ,   2901/2901
(100 %)
3 diff
(99.9 %id)
DA296236 hippocampus .b 1 to 546 7 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA368919 subthalamic nucleus .b 1 to 576 7 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DA529281 brain .b 1 to 608 7 to 614   capped   613/613
(100 %)
3 diff
(99.6 %id)
DA703468   .b 1 to 493 7 to 499   capped   498/498
(100 %)
0 diff
(100 %id)
DA785110 brain .b 1 to 527 7 to 534   capped   533/536
(99 %)
3 diff
(99.5 %id)
BP366023 lung .b 1 to 577 6 to 582       582/582
(100 %)
0 diff
(100 %id)
DA293957 hippocampus .b 1 to 558 6 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
DA374355 thalamus .b 1 to 572 6 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA436514 tongue, tumor tissue .b 1 to 570 6 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
DA480709   .b 1 to 539 6 to 544   capped   543/543
(100 %)
1 diff
(99.9 %id)
DA489137 brain .b 1 to 544 6 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
DA531403 brain .b 1 to 597 6 to 602   capped   601/601
(100 %)
2 diff
(99.7 %id)
DA762858 tongue .b 1 to 566 6 to 571   capped   570/570
(100 %)
3 diff
(99.5 %id)
DA770683 brain .b 1 to 560 6 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
BP313375 mammary gland .b 1 to 579 5 to 583       583/583
(100 %)
2 diff
(99.7 %id)
DA126243 cerebellum .b 1 to 595 5 to 599   capped   598/598
(100 %)
2 diff
(99.7 %id)
DA166301 amygdala .b 1 to 518 5 to 522   capped   521/521
(100 %)
1 diff
(99.9 %id)
AU279846   .b 1 to 561 4 to 564       564/564
(100 %)
0 diff
(100 %id)
DA436410 tongue, tumor tissue .b 1 to 564 5 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DA438653 tongue, tumor tissue .b 1 to 572 5 to 575   capped   574/574
(100 %)
3 diff
(99.5 %id)
DA450830 tongue, tumor tissue .b 1 to 570 5 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA453361 tongue, tumor tissue .b 1 to 551 5 to 555   capped   554/554
(100 %)
3 diff
(99.5 %id)
DA453744 tongue, tumor tissue .b 1 to 567 5 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DA683223   .b 1 to 517 5 to 521   capped   520/520
(100 %)
1 diff
(99.9 %id)
DA726911   .b 1 to 567 5 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DA738762   .b 1 to 540 5 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DA769170 brain .b 1 to 510 5 to 514   capped   513/513
(100 %)
1 diff
(99.9 %id)
DA940893 Spleen .b 1 to 530 5 to 534   capped   533/533
(100 %)
1 diff
(99.9 %id)
DB119804 thymus .b 1 to 530 5 to 534   capped   533/533
(100 %)
1 diff
(99.9 %id)
DB260006 uterus .b 1 to 572 5 to 576   capped   575/575
(100 %)
3 diff
(99.5 %id)
DA054991 cerebellum .b 1 to 554 4 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA082102 cerebellum .b 1 to 530 4 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
DA120498 cerebellum .b 1 to 559 4 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA146332 amygdala .b 1 to 576 4 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
DA203703 brain .b 1 to 570 4 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DA371320 thalamus .b 1 to 536 4 to 539   capped   538/538
(100 %)
1 diff
(99.9 %id)
DA392746 thalamus .b 1 to 588 4 to 591   capped   590/590
(100 %)
1 diff
(99.9 %id)
DA434144 tongue, tumor tissue .b 1 to 516 4 to 519   capped   518/518
(100 %)
0 diff
(100 %id)
DA434477 tongue, tumor tissue .b 1 to 520 4 to 524   capped   523/523
(100 %)
1 diff
(99.9 %id)
DA438086 tongue, tumor tissue .b 1 to 548 4 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DA442323 tongue, tumor tissue .b 1 to 573 4 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA443364 tongue, tumor tissue .b 1 to 564 4 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA443759 tongue, tumor tissue .b 1 to 554 4 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA445386 tongue, tumor tissue .b 1 to 570 4 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA445724 tongue, tumor tissue .b 1 to 583 4 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
DA447878 tongue, tumor tissue .b 1 to 527 4 to 530   capped   529/532
(99 %)
2 diff
(99.7 %id)
DA457189 tongue, tumor tissue .b 1 to 575 4 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
DA576707   .b 1 to 557 4 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
DA578501   .b 1 to 550 4 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
DA649228   .b 1 to 544 4 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
DA652291   .b 1 to 530 4 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
DA656887   .b 1 to 510 4 to 514   capped   513/513
(100 %)
1 diff
(99.9 %id)
DA662094   .b 1 to 536 4 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DA701358   .b 1 to 527 4 to 530   capped   529/532
(99 %)
2 diff
(99.7 %id)
DA744383   .b 1 to 510 4 to 514   capped   513/513
(100 %)
1 diff
(99.9 %id)
DA768510 brain .b 1 to 534 4 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
DA773940 brain .b 1 to 576 4 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
DA775079 brain .b 1 to 574 4 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA776970 brain .b 1 to 568 4 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA780940 brain .b 1 to 554 4 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA866685 Prostate .b 1 to 535 4 to 538   capped   537/540
(99 %)
6 diff
(98.9 %id)
DA944311 Spleen .b 1 to 549 4 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA950591 Spleen .b 1 to 559 4 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA965371 stomach .b 1 to 571 4 to 574   capped   573/576
(99 %)
1 diff
(99.9 %id)
DB004272 breast, tumor tissue .b 1 to 533 4 to 537   capped   536/536
(100 %)
1 diff
(99.9 %id)
DB127537 thymus .b 1 to 510 4 to 513   capped   512/512
(100 %)
0 diff
(100 %id)
DB131938 thymus .b 1 to 486 4 to 490   capped   489/489
(100 %)
1 diff
(99.8 %id)
DB217676 trachea .b 1 to 503 4 to 506   capped   505/505
(100 %)
0 diff
(100 %id)
DB245250 uterus, tumor tissue .b 1 to 527 4 to 531   capped   530/533
(99 %)
2 diff
(99.7 %id)
DB272126 uterus .b 1 to 543 4 to 548   capped   547/547
(100 %)
5 diff
(99.1 %id)
DB136288 thymus .b 1 to 494 3 to 496   capped   495/495
(100 %)
0 diff
(100 %id)
DA460080 tongue, tumor tissue .b 1 to 551 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
BU508963 leiomyosarcoma, uterus .b 10 to 886 1 to 879       879/882
(99 %)
22 diff
(97.6 %id)
CN295021 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 16 to 726 1 to 714       712/714
(99 %)
4 diff
(99.5 %id)
CO245981 Chondrosarcoma Lung Metastasis cell lines, lung .b 19 to 717 1 to 697       697/805
(86 %)
13 diff
(98.4 %id)
BU183507 melanotic melanoma, skin .b 21 to 825 1 to 812       812/913
(88 %)
12 diff
(98.7 %id)
DA660743   .b 22 to 510 2 to 491   capped   490/490
(100 %)
1 diff
(99.8 %id)
AL534547 brain, fetal brain .b 24 to 818 1 to 795       795/795
(100 %)
3 diff
(99.7 %id)
DA453174 tongue, tumor tissue .b 24 to 527 2 to 504   capped   503/506
(99 %)
3 diff
(99.5 %id)
DA701673   .b 24 to 507 2 to 485   capped   484/484
(100 %)
0 diff
(100 %id)
DA447523 tongue, tumor tissue .b 25 to 601 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
CX872413 embryonic stem .b 25 to 744 1 to 720       720/720
(100 %)
0 diff
(100 %id)
DA878422 Prostate .b 25 to 592 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA161954 amygdala .b 28 to 598 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
DA435189 tongue, tumor tissue .b 28 to 570 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DA435785 tongue, tumor tissue .b 28 to 595 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA435905 tongue, tumor tissue .b 28 to 609 2 to 583   capped   582/582
(100 %)
1 diff
(99.9 %id)
DA436844 tongue, tumor tissue .b 28 to 600 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DA495861 brain .b 28 to 606 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA558113   .b 28 to 606 2 to 582   capped   581/581
(100 %)
3 diff
(99.5 %id)
DA601494   .b 28 to 594 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
DA655537   .b 28 to 602 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DA711762   .b 28 to 582 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DB171651 kidney, tumor tissue .b 28 to 325 2 to 299   capped   298/298
(100 %)
0 diff
(100 %id)
BC030556 Blood, adult leukocytes .b 39 to 2896 1 to 2858 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 2858/2858
(100 %)
2 diff
(100.0 %id)
DB206067 trachea .b 40 to 623 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
DA447365 tongue, tumor tissue .b 46 to 624 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA557283   .b 46 to 582 2 to 539   capped   538/538
(100 %)
2 diff
(99.7 %id)
DA768766 brain .b 46 to 584 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DA397611 thalamus .b 47 to 633 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
DA650524   .b 47 to 608 2 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
DA877800 Prostate .b 48 to 612 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DA161219 amygdala .b 49 to 620 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DA291815 hippocampus .b 49 to 633 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
DA319433 hippocampus .b 49 to 608 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA509354 brain .b 49 to 622 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA576617   .b 49 to 628 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA713661   .b 49 to 620 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA797670 brain .b 49 to 609 2 to 562   capped   561/562
(99 %)
1 diff
(99.9 %id)
BC001154 Muscle, rhabdomyosarcoma .b 50 to 2896 1 to 2847 exact available from MGC, AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 2847/2847
(100 %)
2 diff
(100.0 %id)
DA700601   .b 50 to 566 2 to 518   capped   517/517
(100 %)
1 diff
(99.9 %id)
DA719788   .b 50 to 585 2 to 541   capped   540/540
(100 %)
4 diff
(99.3 %id)
BQ927087 large cell carcinoma, lung .b 52 to 889 26 to 866       841/977
(86 %)
17 diff
(98.3 %id)
CA396111 eye, RPE/choroid .b 54 to 541 1 to 488       488/488
(100 %)
0 diff
(100 %id)
DA576763   .b 58 to 619 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
BE299935 muscle, rhabdomyosarcoma .b 69 to 755 1 to 688       688/758
(90 %)
4 diff
(99.5 %id)
BE294030 muscle, rhabdomyosarcoma .b 70 to 738 1 to 667       667/668
(99 %)
7 diff
(99.0 %id)
BP211826 cerebrum .b 73 to 655 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DA164372 amygdala .b 74 to 641 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA494946 brain .b 74 to 641 2 to 571   capped   570/570
(100 %)
3 diff
(99.5 %id)
DA791234 brain .b 74 to 656 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
DB096583 testis .b 74 to 644 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DB261037 uterus .b 74 to 637 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
DA204188 brain .b 76 to 666 2 to 592   capped   591/591
(100 %)
1 diff
(99.9 %id)
DA283415 corpus callosum .b 76 to 612 2 to 540   capped   539/539
(100 %)
2 diff
(99.7 %id)
DA529237 brain .b 76 to 684 2 to 610   capped   609/609
(100 %)
0 diff
(100 %id)
DA023884   .b 79 to 617 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DA447512 tongue, tumor tissue .b 79 to 672 2 to 595   capped   594/594
(100 %)
0 diff
(100 %id)
DA582675 lung .b 79 to 663 2 to 585   capped   584/584
(100 %)
0 diff
(100 %id)
DA717924   .b 79 to 663 2 to 589   capped   588/588
(100 %)
2 diff
(99.7 %id)
DB154321 thymus .b 79 to 663 2 to 585   capped   584/584
(100 %)
1 diff
(99.9 %id)
DA224965 brain .b 84 to 706 2 to 624   capped   623/623
(100 %)
1 diff
(99.9 %id)
BP274831 Kidney .b 85 to 664 1 to 580       580/584
(99 %)
1 diff
(99.9 %id)
AB021868   .b 88 to 2896 1 to 2808       2808/2808
(100 %)
3 diff
(99.9 %id)
BI823858 pooled brain, lung, testis .b 90 to 807 1 to 719       719/719
(100 %)
3 diff
(99.6 %id)
TI_57201124   .b 90 to 807 65 to 783       719/783
(91 %)
9 diff
(98.9 %id)
BU178124 melanotic melanoma, skin .b 94 to 889 1 to 798       798/887
(89 %)
10 diff
(98.9 %id)
DA455383 tongue, tumor tissue .b 99 to 660 15 to 576   capped   562/575
(97 %)
0 diff
(100 %id)
CO248513 Chondrosarcoma Lung Metastasis cell lines, lung .b 108 to 748 35 to 668       634/794
(79 %)
12 diff
(98.5 %id)
TI_1948086357   .b 112 to 1068 136 to 1099       962/1341
(71 %)
19 diff
(98.6 %id)
TI_1948086703   .b 112 to 1000 134 to 1020   AAA   887/1339
(66 %)
23 diff
(98.3 %id)
TI_1948086876   .b 112 to 1000 135 to 1024       890/1360
(65 %)
18 diff
(98.7 %id)
BT007036   .b 113 to 1970 1 to 1858       1858/1860
(99 %)
1 diff
(100.0 %id)
CR457090   .b 113 to 1968 1 to 1856       1856/1860
(99 %)
2 diff
(99.9 %id)
CV025835 mixed .b 113 to 686 1 to 574       574/574
(100 %)
0 diff
(100 %id)
BM452958 melanotic melanoma, skin .b 275 to 1079 1 to 808       808/918
(88 %)
10 diff
(99.0 %id)
BM452955 melanotic melanoma, skin .b 277 to 995 1 to 720       720/891
(80 %)
14 diff
(98.5 %id)
CR590421 B cells (Ramos cell line) Cot 25-normalized .b 283 to 2086 1 to 1804       1804/1804
(100 %)
0 diff
(100 %id)
AL582931 B cells from Burkitt lymphoma .b 283 to 1326 1 to 1036       1037/1036
(100 %)
11 diff
(99.0 %id)
DA557197   .b 373 to 929 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA888941   .b 381 to 939 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DB202767 trachea .b 463 to 976 2 to 516   capped   515/515
(100 %)
3 diff
(99.5 %id)
CV815401 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 518 to 1357 1 to 847       847/882
(96 %)
21 diff
(97.7 %id)
DA543208   .b 538 to 1091 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
CN295031 embryonic stem cells, cell lines H1, H7, andH9 .b 558 to 1227 1 to 671       671/671
(100 %)
1 diff
(99.9 %id)
DA882809   .b 558 to 1102 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
BP269855 thyroid .b 564 to 1147 1 to 584       584/584
(100 %)
0 diff
(100 %id)
DA603590   .b 566 to 1360 2 to 795   capped   794/794
(100 %)
1 diff
(99.9 %id)
AW245807 lung, small cell carcinoma .b 622 to 1249 10 to 637     Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 628/637
(98 %)
8 diff
(98.8 %id)
CN295024 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 635 to 1256 1 to 622       622/622
(100 %)
0 diff
(100 %id)
DA731175   .b 719 to 1514 2 to 793   capped   792/792
(100 %)
16 diff
(98.0 %id)
DA866967 Prostate .b 769 to 1318 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DB259495 uterus .b 772 to 1350 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA890374 rectum .b 777 to 1329 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA901730   .b 907 to 1414 2 to 509   capped   508/508
(100 %)
0 diff
(100 %id)
BQ436701 melanotic melanoma, skin .b 928 to 1703 1 to 781       781/898
(86 %)
14 diff
(98.5 %id)
BE793702 lung, small cell carcinoma .b 945 to 1809 1 to 855       857/900
(95 %)
17 diff
(98.2 %id)
AL122061 breast cancer .b 1011 to 2896 1 to 1886   available from DKFZ, AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 1886/1886
(100 %)
3 diff
(99.9 %id)
TI_1948086358   .b 1070 to 1971 1021 to 130       892/1388
(64 %)
30 diff
(97.9 %id)
CN295029 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 1091 to 1620 1 to 530       530/530
(100 %)
0 diff
(100 %id)
BE784472 large cell carcinoma, lung .b 1101 to 1834 1 to 732       732/777
(94 %)
9 diff
(98.9 %id)
TI_1948086877   .b 1105 to 1971 1002 to 128       875/1406
(62 %)
32 diff
(97.8 %id)
CN295025 embryonic stem cells, cell lines H1, H7, andH9 .b 1121 to 1755 1 to 635       635/635
(100 %)
2 diff
(99.7 %id)
CB156534 brain .b 1142 to 1771 1 to 630       630/630
(100 %)
0 diff
(100 %id)
BM701760 eye, optic nerve .b 1176 to 1836 1 to 659     Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 659/659
(100 %)
2 diff
(99.7 %id)
BX372315   .b 1232 to 2086 855 to 1       855/937
(91 %)
13 diff
(98.7 %id)
BP268594 thyroid .b 1237 to 1817 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
TI_1948086704   .b 1241 to 1971 857 to 128       730/1426
(51 %)
11 diff
(99.3 %id)
BM715935 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 1254 to 1959 1 to 705       705/705
(100 %)
1 diff
(99.9 %id)
BQ924005 epidermoid carcinoma, cell line, lung .b 1272 to 2040 1 to 782       782/1009
(77 %)
22 diff
(97.9 %id)
BE908937 epithelioid carcinoma, Pancreas .b 1284 to 2004 1 to 720       720/897
(80 %)
16 diff
(98.3 %id)
BI256623 cervical carcinoma cell line, cervix .b 1418 to 2277 1 to 867       867/867
(100 %)
21 diff
(97.6 %id)
CA489770   .b 1460 to 2352 1 to 904       904/904
(100 %)
15 diff
(98.4 %id)
BQ921259 leiomyosarcoma, uterus .b 1471 to 2362 1 to 905       905/935
(96 %)
18 diff
(98.1 %id)
BQ921265 leiomyosarcoma, uterus .b 1471 to 2375 1 to 911       911/913
(99 %)
27 diff
(97.1 %id)
CN295030 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 1479 to 2095 1 to 618       618/618
(100 %)
2 diff
(99.7 %id)
CD242403 brain, Pituitary .b 1505 to 2296 1 to 801       801/928
(86 %)
20 diff
(97.9 %id)
CB158728 Liver .b 1538 to 2105 1 to 568       568/568
(100 %)
0 diff
(100 %id)
BG427565 Kidney .b 1569 to 2398 1 to 833       833/834
(99 %)
20 diff
(97.7 %id)
BI084448 epidermoid carcinoma, cell line, salivary gland .b 1573 to 2060 1 to 489   fully sequenced,   489/489
(100 %)
5 diff
(99.0 %id)
TI_57190152   .b 1609 to 2402 51 to 859       809/850
(95 %)
37 diff
(95.7 %id)
AA375243 lung .b 1688 to 1835 1 to 148       148/148
(100 %)
0 diff
(100 %id)
AL565560 brain, fetal brain .b 2025 to 2874 846 to 1       846/846
(100 %)
18 diff
(97.9 %id)
BI085053 epidermoid carcinoma, cell line, salivary gland .b 2030 to 2858 876 to 47   fully sequenced,   830/876
(94 %)
60 diff
(93.2 %id)
DB363269   .b 2340 to 2895 553 to 1       553/553
(100 %)
9 diff
(98.4 %id)
BM666610 eye, optic nerve .b 2372 to 2896 544 to 19   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 526/526
(100 %)
4 diff
(99.3 %id)
AW245449 lung, small cell carcinoma .b 2389 to 2896 518 to 11   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 508/508
(100 %)
3 diff
(99.5 %id)
DC335669 hippocampus .c 1 to 577 7 to 582       582/593
(98 %)
1 diff
(99.9 %id)
DC310732 cerebellum .c 1 to 583 6 to 588   tiling clone,   588/588
(100 %)
3 diff
(99.5 %id)
DC346501 tongue, tumor tissue .c 1 to 582 6 to 587       587/587
(100 %)
4 diff
(99.4 %id)
DC420732 uterus .c 1 to 573 6 to 578       578/578
(100 %)
1 diff
(99.9 %id)
DC308100 cerebellum .c 1 to 572 5 to 576       576/576
(100 %)
1 diff
(99.9 %id)
DC316844 amygdala .c 1 to 553 5 to 557       557/557
(100 %)
2 diff
(99.7 %id)
DC323618 brain .c 1 to 591 5 to 595       595/595
(100 %)
4 diff
(99.4 %id)
DC382162 placenta .c 1 to 542 5 to 546       546/546
(100 %)
2 diff
(99.7 %id)
DC303959 cerebellum .c 1 to 541 4 to 544       544/544
(100 %)
0 diff
(100 %id)
DC307138 cerebellum .c 1 to 565 4 to 568       568/568
(100 %)
1 diff
(99.9 %id)
DC309677 cerebellum .c 1 to 574 4 to 577       577/577
(100 %)
0 diff
(100 %id)
DC366355   .c 1 to 540 4 to 544       544/544
(100 %)
1 diff
(99.9 %id)
DC394384 esophageal, tumor tissue .c 1 to 568 4 to 571       571/571
(100 %)
0 diff
(100 %id)
BP365437 lung .c 1 to 579 4 to 582       582/582
(100 %)
0 diff
(100 %id)
DC417222 trachea .c 1 to 548 4 to 551       551/551
(100 %)
0 diff
(100 %id)
AK294231 amygdala .c 27 to 1068 1 to 1042   tiling clone,   1042/1042
(100 %)
0 diff
(100 %id)
DC313927 amygdala .c 27 to 612 1 to 586       586/586
(100 %)
0 diff
(100 %id)
DC355725   .c 27 to 605 1 to 579       579/579
(100 %)
0 diff
(100 %id)
DC402355 testis .c 27 to 550 1 to 525       525/525
(100 %)
2 diff
(99.7 %id)
DC355806   .c 29 to 597 1 to 569       569/569
(100 %)
2 diff
(99.7 %id)
BI463948 testis .c 36 to 769 1 to 735       735/735
(100 %)
15 diff
(98.0 %id)
DC399561 testis .c 45 to 584 7 to 548       542/548
(98 %)
9 diff
(98.4 %id)
DC303157 cerebellum .c 48 to 589 1 to 542       542/542
(100 %)
0 diff
(100 %id)
DC392098 Spleen .c 48 to 603 1 to 558       558/558
(100 %)
2 diff
(99.7 %id)
DC331193 hippocampus .c 72 to 543 1 to 474       474/474
(100 %)
2 diff
(99.6 %id)
DC377804 brain .c 73 to 633 1 to 561       561/561
(100 %)
0 diff
(100 %id)
DC383986 Prostate .c 73 to 629 1 to 557       557/557
(100 %)
0 diff
(100 %id)
DC320767 brain .c 75 to 622 1 to 548       548/548
(100 %)
0 diff
(100 %id)
DC303403 cerebellum .c 78 to 648 1 to 571       571/571
(100 %)
0 diff
(100 %id)
DC306151 cerebellum .c 78 to 633 1 to 558       558/558
(100 %)
2 diff
(99.7 %id)
DC309615 cerebellum .c 257 to 800 1 to 544       544/544
(100 %)
1 diff
(99.9 %id)
AI903828 breast .c 370 to 867 1 to 493       493/503
(98 %)
8 diff
(98.5 %id)
AI903822 breast .c 371 to 867 1 to 490       493/599
(82 %)
14 diff
(97.7 %id)
AI275065 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 510 to 762 345 to 93       253/345
(73 %)
0 diff
(100 %id)
ES308837 beard hair, skin .c 580 to 753 1 to 175       175/175
(100 %)
1 diff
(99.5 %id)
BI488513 brain .c 907 to 1802 1 to 899   tiling clone,   899/1004
(89 %)
19 diff
(98.2 %id)
TI_45379021   .c 911 to 1802 65 to 959       895/1064
(84 %)
25 diff
(97.7 %id)
BP377967 uterus .c 1337 to 1918 1 to 582   tiling clone,   582/582
(100 %)
0 diff
(100 %id)
BI489462 brain .c 2436 to 2935 521 to 7   tiling clone,   515/1154
(44 %)
0 diff
(100 %id)
TI_45379022   .c 2436 to 2935 521 to 7       515/1154
(44 %)
0 diff
(100 %id)
AK125158 brain .d 1 to 2678 2 to 2679 exact tiling clone, available from FLJ,   2679/2679
(100 %)
2 diff
(100.0 %id)
DA492700 brain .d 1 to 464 2 to 465   capped   464/464
(100 %)
0 diff
(100 %id)
DA589640 lung .d 300 to 856 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DB114372 thymus .d 504 to 1062 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA939628 Spleen .d 533 to 1115 2 to 584   capped   583/583
(100 %)
3 diff
(99.5 %id)
CF146675 CNCAP(3)T-225 cell line, Prostate .d 1482 to 2091 1 to 610       610/610
(100 %)
4 diff
(99.4 %id)
CF146730 CNCAP(3)T-225 cell line, Prostate .d 1482 to 2184 1 to 701       701/701
(100 %)
8 diff
(98.9 %id)
TI_154179176   .d 1488 to 2314 70 to 875       806/900
(89 %)
25 diff
(97.3 %id)
TI_154179243   .d 1488 to 2314 69 to 890       822/823
(99 %)
7 diff
(99.2 %id)
W84502 liver and spleen .d 1496 to 1929 1 to 431       431/431
(100 %)
14 diff
(96.8 %id)
CX786191 human embryonic stem cells .d 1499 to 2243 1 to 745       745/745
(100 %)
0 diff
(100 %id)
AI547314 Prostate .d 1506 to 2233 1 to 721       721/723
(99 %)
20 diff
(97.3 %id)
BG164500 hypernephroma, cell line, Kidney .d 1509 to 2296 1 to 780       780/909
(85 %)
20 diff
(97.8 %id)
AA337037 endometrium .d 1553 to 1806 1 to 255       255/255
(100 %)
1 diff
(99.7 %id)
AL582881 B cells from Burkitt lymphoma .d 1573 to 2646 1067 to 1       1067/1105
(96 %)
22 diff
(98.1 %id)
AA321076 adipose tissue, white .d 1628 to 1966 1 to 340       340/341
(99 %)
5 diff
(98.6 %id)
BX420251 brain, fetal brain .d 1681 to 2664 995 to 1   tiling clone,   995/995
(100 %)
61 diff
(93.9 %id)
AA373948 lung .d 1691 to 1996 1 to 310       310/310
(100 %)
6 diff
(98.1 %id)
AW957526   .d 1692 to 2137 1 to 446       446/446
(100 %)
8 diff
(98.3 %id)
TI_154053875   .d 1718 to 2678 1036 to 85   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 952/1003
(94 %)
38 diff
(96.3 %id)
BQ270914 insulinoma, Pancreas .d 1725 to 2278 1 to 554       554/554
(100 %)
5 diff
(99.1 %id)
CK825372 insulinoma, Pancreas .d 1725 to 2304 1 to 580       580/580
(100 %)
5 diff
(99.2 %id)
BX282313 embryonal carcinoma, cell line, testis .d 1736 to 2223 1 to 488       488/488
(100 %)
1 diff
(99.8 %id)
BQ221451 embryonal carcinoma, cell line, testis .d 1737 to 2547 1 to 822       822/833
(98 %)
14 diff
(98.4 %id)
BQ883087 brain, neuroblastoma, cell line .d 1789 to 2519 22 to 759   AAA   738/962
(76 %)
13 diff
(98.7 %id)
BQ957576 carcinoma, cell line, Prostate .d 1811 to 2635 49 to 877       829/963
(86 %)
32 diff
(96.7 %id)
AW881388 ovary .d 1844 to 2130 1 to 284       284/287
(98 %)
8 diff
(97.3 %id)
BE694581 breast .d 1844 to 2206 1 to 361       361/371
(97 %)
6 diff
(98.4 %id)
BU507706 leiomyosarcoma, uterus .d 1852 to 2678 1 to 828       828/833
(99 %)
7 diff
(99.2 %id)
BU856993 adenocarcinoma, cell line, breast .d 1863 to 2678 1 to 820       820/951
(86 %)
12 diff
(98.8 %id)
TI_149298760   .d 1887 to 2678 875 to 92   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 784/963
(81 %)
9 diff
(99.1 %id)
TI_149302107   .d 1887 to 2678 875 to 88   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 788/978
(80 %)
9 diff
(99.1 %id)
TI_149312535   .d 1887 to 2678 874 to 89   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 786/964
(81 %)
10 diff
(99.0 %id)
BM978104 lung .d 1914 to 2678 779 to 19   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 761/761
(100 %)
7 diff
(99.1 %id)
BQ019068 lung, Metastatic Chondrosarcoma .d 1947 to 2678 748 to 19   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 730/730
(100 %)
4 diff
(99.5 %id)
R47801 breast .d 1948 to 2236 1 to 295   fully sequenced,   295/295
(100 %)
10 diff
(96.7 %id)
BM975457 lung, Primary Lung Cystic Fibrosis EpithelialCells .d 1962 to 2678 735 to 19   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 717/717
(100 %)
4 diff
(99.5 %id)
CD621977   .d 1963 to 2136 8 to 182       175/200
(87 %)
2 diff
(99.0 %id)
BU624510 cell lines, Enchondroma .d 1978 to 2678 717 to 19   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 699/699
(100 %)
5 diff
(99.3 %id)
FN057901 breast carcinoma .d 1981 to 2060 1 to 80       80/80
(100 %)
2 diff
(97.5 %id)
BG027542 Bone, osteosarcoma, cell line .d 1989 to 2679 1 to 689       689/710
(97 %)
13 diff
(98.2 %id)
CA422590 cell lines, Chondrosarcoma .d 2016 to 2678 681 to 19   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 663/663
(100 %)
2 diff
(99.7 %id)
AL043045.
matches multiple genes
testis .d 2026 to 2678 697 to 44   AAA also hits gene teebler 654/678
(96 %)
0 diff
(100 %id)
CA952818 Pancreas, Purified pancreatic islet .d 2076 to 2359 1 to 285   fully sequenced,   285/285
(100 %)
5 diff
(98.3 %id)
BU753520 placenta .d 2091 to 2678 604 to 18   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 587/587
(100 %)
3 diff
(99.5 %id)
AA242958 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 2105 to 2439 1 to 334   fully sequenced,   334/334
(100 %)
4 diff
(98.9 %id)
BU608702 Human Lung Epithelial cells, lung .d 2107 to 2678 589 to 19   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 571/674
(84 %)
4 diff
(99.5 %id)
AI829713 pooled .d 2123 to 2678 562 to 7       556/562
(98 %)
0 diff
(100 %id)
BM677540 eye, fetal eye .d 2131 to 2678 567 to 19   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 549/549
(100 %)
3 diff
(99.5 %id)
BM548178 brain, hippocampus .d 2134 to 2677 20 to 562       543/1203
(45 %)
4 diff
(99.7 %id)
BQ270667 insulinoma, Pancreas .d 2137 to 2678 557 to 16   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 542/542
(100 %)
2 diff
(99.7 %id)
CA430588 Cell Line, Chondrosarcoma .d 2142 to 2678 556 to 19   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 538/538
(100 %)
3 diff
(99.5 %id)
AI826499 normal prostate, Prostate .d 2145 to 2678 534 to 1       534/534
(100 %)
2 diff
(99.7 %id)
BM980364 lung, Primary Lung Cystic Fibrosis EpithelialCells .d 2151 to 2678 547 to 19   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 529/529
(100 %)
3 diff
(99.5 %id)
BU618557 Cell Line, Chondrosarcoma .d 2153 to 2678 544 to 19   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 526/526
(100 %)
2 diff
(99.7 %id)
AI912299 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 2166 to 2678 520 to 9       512/520
(98 %)
0 diff
(100 %id)
AW148712 brain, tumor, 5 pooled (see description) .d 2166 to 2678 516 to 3       514/516
(99 %)
0 diff
(100 %id)
BM682358 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 2174 to 2678 522 to 19   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 504/506
(99 %)
8 diff
(98.5 %id)
EL948416 eyeball .d 2180 to 2678 1 to 499   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 499/499
(100 %)
7 diff
(98.6 %id)
BM717827 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 2181 to 2678 1 to 498   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 498/498
(100 %)
2 diff
(99.6 %id)
AA827585 Kidney, kidney tumor .d 2183 to 2678 505 to 10       496/505
(98 %)
0 diff
(100 %id)
AI969463 malignant melanoma, metastatic to lymphnode, skin .d 2187 to 2678 492 to 1       492/492
(100 %)
2 diff
(99.6 %id)
TI_154034608   .d 2187 to 2678 563 to 67   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 497/812
(61 %)
20 diff
(97.6 %id)
AA370862 Prostate .d 2200 to 2549 1 to 350       350/350
(100 %)
6 diff
(98.3 %id)
BE464672 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .d 2207 to 2678 472 to 1       472/472
(100 %)
2 diff
(99.6 %id)
AI924695 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 2208 to 2678 477 to 7       471/477
(98 %)
0 diff
(100 %id)
AI985786 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 2209 to 2678 472 to 3       470/472
(99 %)
0 diff
(100 %id)
AA652621 normal prostate, Prostate .d 2211 to 2678 470 to 3       468/470
(99 %)
0 diff
(100 %id)
AA678240 liver and spleen .d 2213 to 2678 461 to 1       461/461
(100 %)
8 diff
(98.3 %id)
AI911877 colon .d 2213 to 2678 469 to 4       466/469
(99 %)
0 diff
(100 %id)
BQ012514 placenta .d 2224 to 2678 472 to 19   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 454/454
(100 %)
7 diff
(98.5 %id)
R49951 breast .d 2226 to 2669 459 to 10   fully sequenced,   450/459
(98 %)
0 diff
(100 %id)
BM727978 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .d 2226 to 2678 1 to 451   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 451/451
(100 %)
4 diff
(99.2 %id)
AW027386 thymus, pooled .d 2227 to 2662 436 to 1       436/436
(100 %)
4 diff
(99.1 %id)
AW962871   .d 2234 to 2675 1 to 440       440/563
(78 %)
13 diff
(97.7 %id)
W84735 liver and spleen .d 2235 to 2678 450 to 1       450/452
(99 %)
19 diff
(95.8 %id)
AW150867 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 2235 to 2678 462 to 19   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 444/444
(100 %)
12 diff
(97.3 %id)
CA442039 lung, Metastatic Chondrosarcoma .d 2237 to 2678 461 to 19   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 443/447
(99 %)
5 diff
(98.9 %id)
AI085699 senescent fibroblast .d 2243 to 2678 440 to 6       435/440
(98 %)
0 diff
(100 %id)
AW661719 pooled .d 2247 to 2677 427 to 1       427/430
(99 %)
8 diff
(98.2 %id)
AI337930 uterus .d 2250 to 2678 430 to 2       429/430
(99 %)
0 diff
(100 %id)
AI814626 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .d 2254 to 2668 452 to 38       415/452
(91 %)
0 diff
(100 %id)
AI269043 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 2259 to 2678 421 to 2       420/421
(99 %)
0 diff
(100 %id)
AI627452 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .d 2259 to 2678 420 to 1       420/420
(100 %)
2 diff
(99.6 %id)
AW087580 pooled .d 2259 to 2678 424 to 4       421/424
(99 %)
0 diff
(100 %id)
AI343754 2 pooled tumors (clear cell type), Kidney .d 2260 to 2678 422 to 4       419/422
(99 %)
0 diff
(100 %id)
AW469183 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .d 2260 to 2678 419 to 1       419/419
(100 %)
2 diff
(99.6 %id)
AI334357 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 2262 to 2678 429 to 13   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 417/417
(100 %)
7 diff
(98.4 %id)
AI420824 Prostate .d 2262 to 2678 418 to 2       417/418
(99 %)
0 diff
(100 %id)
AA928713 adenocarcinoma, colon .d 2265 to 2678 413 to 1       413/413
(100 %)
6 diff
(98.6 %id)
AW475033 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 2270 to 2678 409 to 1       409/409
(100 %)
2 diff
(99.6 %id)
AI753265 bone marrow stroma .d 2271 to 2678 426 to 20   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 407/407
(100 %)
3 diff
(99.3 %id)
AI262779 Kidney .d 2274 to 2678 402 to 1       402/402
(100 %)
5 diff
(98.8 %id)
AI337938 uterus .d 2275 to 2678 404 to 1       404/404
(100 %)
2 diff
(99.6 %id)
BQ227688 epithelioid carcinoma, Pancreas .d 2292 to 2678 1 to 387   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 387/387
(100 %)
2 diff
(99.5 %id)
AI222874 adenocarcinoma, colon .d 2311 to 2678 367 to 1       367/372
(98 %)
2 diff
(99.5 %id)
AA729236 pooled germ cell tumors .d 2312 to 2678 368 to 3       366/368
(99 %)
0 diff
(100 %id)
BE350133 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .d 2319 to 2678 376 to 17   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 360/360
(100 %)
5 diff
(98.7 %id)
CA952617 Pancreas, Purified pancreatic islet .d 2329 to 2677 349 to 1   fully sequenced,   349/349
(100 %)
2 diff
(99.5 %id)
AA676438 liver and spleen .d 2345 to 2678 335 to 2       334/335
(99 %)
0 diff
(100 %id)
AI432156 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 2349 to 2678 333 to 5       329/333
(98 %)
0 diff
(100 %id)
CA443676 lung, Metastatic Chondrosarcoma .d 2356 to 2678 341 to 19   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 323/323
(100 %)
2 diff
(99.4 %id)
AA631065 normal prostate, Prostate .d 2358 to 2678 322 to 3       320/322
(99 %)
0 diff
(100 %id)
AA594758 breast .d 2382 to 2678 317 to 22   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 296/296
(100 %)
4 diff
(98.7 %id)
AI082512   .d 2383 to 2678 302 to 10       293/302
(97 %)
0 diff
(100 %id)
DB315483 brain .d 2386 to 2678 293 to 1       293/293
(100 %)
2 diff
(99.4 %id)
H06727 whole brain .d 2398 to 2678 302 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 284/284
(100 %)
6 diff
(97.9 %id)
AI471091 brain, glioblastoma (pooled) .d 2398 to 2678 281 to 1       281/281
(100 %)
2 diff
(99.3 %id)
AI452580 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .d 2404 to 2678 275 to 1       275/275
(100 %)
2 diff
(99.3 %id)
AI701726 pooled .d 2404 to 2678 276 to 2       275/276
(99 %)
0 diff
(100 %id)
AI678379 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .d 2405 to 2678 298 to 25   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 274/274
(100 %)
6 diff
(97.9 %id)
AA242823 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 2409 to 2678 270 to 1   fully sequenced,   270/270
(100 %)
2 diff
(99.3 %id)
AI079620 senescent fibroblast .d 2415 to 2678 278 to 15   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 264/264
(100 %)
5 diff
(98.2 %id)
AI783470 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d 2422 to 2678 256 to 1       256/256
(100 %)
3 diff
(98.9 %id)
AA370861 Prostate .d 2430 to 2678 249 to 1       249/249
(100 %)
2 diff
(99.2 %id)
AA704412 liver and spleen .d 2431 to 2678 247 to 1       247/247
(100 %)
4 diff
(98.4 %id)
AI382973 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 2442 to 2678 241 to 6       236/241
(97 %)
0 diff
(100 %id)
AA890670 parathyroid gland, parathyroid tumor .d 2461 to 2587 127 to 1       127/127
(100 %)
1 diff
(99.3 %id)
AI571074 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .d 2461 to 2678 236 to 20   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 217/217
(100 %)
5 diff
(97.7 %id)
AI564686 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 2463 to 2678 242 to 27   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 216/216
(100 %)
7 diff
(96.8 %id)
AI564671 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 2472 to 2678 237 to 31   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 207/207
(100 %)
7 diff
(96.7 %id)
AI420826 Prostate .d 2498 to 2669 172 to 1       172/172
(100 %)
4 diff
(97.7 %id)
AI935844 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .d 2529 to 2678 167 to 18   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 150/150
(100 %)
2 diff
(98.7 %id)
AI561327 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 2542 to 2678 152 to 15   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 138/138
(100 %)
1 diff
(99.3 %id)
DC406683 thymus .e 1 to 532 1 to 532   tiling clone,   532/532
(100 %)
1 diff
(99.9 %id)
CN295022 embryonic stem cells, cell lines H1, H7, andH9 .e 7 to 582 1 to 576       576/576
(100 %)
1 diff
(99.9 %id)
DC370693   .e 9 to 576 1 to 568       568/568
(100 %)
2 diff
(99.7 %id)
DC337796 substantia nigra .e 10 to 599 1 to 590       590/591
(99 %)
1 diff
(99.9 %id)
DC337828 substantia nigra .e 10 to 564 1 to 556       556/556
(100 %)
2 diff
(99.7 %id)
DC340825 thalamus .e 10 to 602 1 to 593   tiling clone,   593/593
(100 %)
1 diff
(99.9 %id)
DC346322 tongue, tumor tissue .e 10 to 582 1 to 573       573/573
(100 %)
1 diff
(99.9 %id)
DC346816 tongue, tumor tissue .e 10 to 577 1 to 568       568/568
(100 %)
1 diff
(99.9 %id)
DC365279   .e 10 to 567 1 to 560       560/560
(100 %)
3 diff
(99.5 %id)
DC383173 Prostate .e 10 to 563 1 to 554       554/554
(100 %)
1 diff
(99.9 %id)
DC392096 Spleen .e 10 to 550 1 to 541       541/541
(100 %)
1 diff
(99.9 %id)
DC410654 thymus .e 10 to 587 1 to 578       578/578
(100 %)
2 diff
(99.7 %id)
DC410838 thymus .e 10 to 597 1 to 588       588/588
(100 %)
1 diff
(99.9 %id)
DC346091 tongue, tumor tissue .e 11 to 584 1 to 574       574/574
(100 %)
2 diff
(99.7 %id)
BM754907 stomach .e 11 to 451 1 to 441   tiling clone,   441/441
(100 %)
4 diff
(99.1 %id)
DC410450 thymus .e 12 to 602 1 to 591       591/591
(100 %)
2 diff
(99.7 %id)
DC346256 tongue, tumor tissue .e 30 to 612 1 to 583       583/583
(100 %)
0 diff
(100 %id)
DC408173 thymus .e 32 to 581 1 to 550       550/550
(100 %)
0 diff
(100 %id)
DC345537 tongue, tumor tissue .e 33 to 308 1 to 276       276/276
(100 %)
1 diff
(99.7 %id)
DC346445 tongue, tumor tissue .e 39 to 613 1 to 575       575/575
(100 %)
0 diff
(100 %id)
DC346895 tongue, tumor tissue .e 41 to 595 1 to 555       555/555
(100 %)
0 diff
(100 %id)
TI_154136948   .e 45 to 828 59 to 837     Submitted on the opposite strand 779/1258
(61 %)
22 diff
(98.3 %id)
AW297008   .e 46 to 514 1 to 469     Submitted on the opposite strand 469/469
(100 %)
0 diff
(100 %id)
DC364228   .e 54 to 607 1 to 554       554/555
(99 %)
6 diff
(99.0 %id)
DC345325 tongue, tumor tissue .e 57 to 827 1 to 781       779/840
(92 %)
13 diff
(98.5 %id)
DC428867   .e 63 to 477 182 to 596       415/596
(69 %)
6 diff
(99.0 %id)
DC421352 uterus .e 63 to 579 1 to 517       517/517
(100 %)
0 diff
(100 %id)
DC301878   .e 64 to 608 1 to 545       545/545
(100 %)
1 diff
(99.9 %id)
DC308923 cerebellum .e 64 to 634 1 to 571       571/571
(100 %)
0 diff
(100 %id)
CB993899 placenta, pre-eclamptic placenta .e 64 to 603 28 to 572       545/979
(55 %)
18 diff
(98.2 %id)
CB993821 placenta, pre-eclamptic placenta .e 64 to 843 28 to 808       781/809
(96 %)
12 diff
(98.6 %id)
DC363486   .e 66 to 657 1 to 592       592/592
(100 %)
0 diff
(100 %id)
AK304039 trachea .e 67 to 1301 1 to 1235 L132F tiling clone,   1235/1235
(100 %)
2 diff
(99.9 %id)
DC345556 tongue, tumor tissue .e 67 to 645 1 to 579       579/579
(100 %)
0 diff
(100 %id)
DC415605 trachea .e 67 to 608 1 to 542       542/542
(100 %)
1 diff
(99.9 %id)
BE732049 choriocarcinoma, placenta .e 68 to 599 1 to 534       534/638
(83 %)
4 diff
(99.4 %id)
DC346782 tongue, tumor tissue .e 69 to 352 1 to 284       284/284
(100 %)
1 diff
(99.7 %id)
AL602572 human skeletal muscle .e 69 to 599 1 to 531       531/531
(100 %)
1 diff
(99.9 %id)
CD695702 normal nasopharynx .e 72 to 687 34 to 649       616/649
(94 %)
6 diff
(99.1 %id)
DC424995   .e 72 to 629 1 to 558       558/558
(100 %)
0 diff
(100 %id)
DC345603 tongue, tumor tissue .e 72 to 636 1 to 565       565/565
(100 %)
0 diff
(100 %id)
DC345810 tongue, tumor tissue .e 72 to 622 1 to 551       551/551
(100 %)
0 diff
(100 %id)
DC346458 tongue, tumor tissue .e 72 to 647 1 to 576       576/576
(100 %)
0 diff
(100 %id)
DC348642   .e 72 to 537 1 to 466       466/466
(100 %)
0 diff
(100 %id)
DC364631   .e 72 to 640 1 to 569       569/569
(100 %)
0 diff
(100 %id)
DC367709   .e 72 to 582 1 to 511       511/511
(100 %)
0 diff
(100 %id)
DC386887   .e 74 to 646 1 to 573       573/573
(100 %)
0 diff
(100 %id)
DB477864.
matches multiple genes
hippocampus .e 81 to 349 1 to 269     also hits gene NUDT17 269/269
(100 %)
6 diff
(97.8 %id)
DC346833 tongue, tumor tissue .e 82 to 445 189 to 552       364/552
(65 %)
6 diff
(99.0 %id)
DC388459 small intestine .e 82 to 668 1 to 587       587/587
(100 %)
3 diff
(99.5 %id)
DC345761 tongue, tumor tissue .e 83 to 644 1 to 562       562/562
(100 %)
0 diff
(100 %id)
DC376043 brain .e 83 to 629 1 to 547       547/547
(100 %)
0 diff
(100 %id)
DC388566 small intestine .e 83 to 674 1 to 593       593/593
(100 %)
1 diff
(99.9 %id)
DC388714 small intestine .e 83 to 654 1 to 572       572/572
(100 %)
0 diff
(100 %id)
DC393762 esophageal, tumor tissue .e 83 to 642 1 to 560       560/560
(100 %)
0 diff
(100 %id)
BX643189   .e 84 to 590 1 to 507       507/507
(100 %)
2 diff
(99.7 %id)
BQ949049 sciatic nerve .e 89 to 961 1 to 877       875/910
(96 %)
17 diff
(98.2 %id)
DC346737 tongue, tumor tissue .e 91 to 648 1 to 559       559/559
(100 %)
4 diff
(99.3 %id)
CN295023 embryonic stem cells, cell lines H1, H7, andH9 .e 94 to 680 1 to 587       587/587
(100 %)
0 diff
(100 %id)
DN995344 breast cancer, Mammary gland (cancer tissue) .e 108 to 633 9 to 534       526/534
(98 %)
0 diff
(100 %id)
DC391257 Spleen .e 113 to 687 1 to 577       577/577
(100 %)
3 diff
(99.5 %id)
CN295027 embryonic stem cells, cell lines H1, H7, andH9 .e 118 to 763 1 to 646       646/646
(100 %)
2 diff
(99.7 %id)
DA401695 thalamus .e 632 to 1097 2 to 467   tiling clone, capped   466/466
(100 %)
0 diff
(100 %id)
BI015642 lung_tumor .e 841 to 1070 241 to 12       230/244
(94 %)
0 diff
(100 %id)
DA282594 corpus callosum .f 1 to 575 2 to 576 F123L tiling clone, capped   575/575
(100 %)
1 diff
(99.9 %id)
DA182599 amygdala .g 1 to 572 2 to 573 exact tiling clone, capped   572/572
(100 %)
0 diff
(100 %id)
DA967809 stomach .h 1 to 556 2 to 556 Y80F N84T L85S F86L V87S ... tiling clone, capped   555/555
(100 %)
2 diff
(99.7 %id)
AK296861 tongue, tumor tissue .i 1 to 868 2 to 869 exact tiling clone,   869/869
(100 %)
0 diff
(100 %id)
DC346915 tongue, tumor tissue .i 1 to 577 2 to 578 R70X     578/578
(100 %)
0 diff
(100 %id)
BX398909 Placenta Cot 25-normalized .j 1 to 1023 2 to 1010 exact tiling clone,   1010/1021
(98 %)
19 diff
(98.2 %id)
DA076424 cerebellum .k 1 to 576 2 to 577 exact tiling clone, capped   576/576
(100 %)
0 diff
(100 %id)
DA443798 tongue, tumor tissue .l 1 to 563 2 to 564 exact tiling clone, capped   563/564
(99 %)
1 diff
(99.9 %id)
CA393225 eye, RPE/choroid .m 1 to 429 1 to 429 exact tiling clone,   429/429
(100 %)
1 diff
(99.8 %id)
CN295028 embryonic stem cells, DMSO-treated H9 cellline .n 1 to 633 1 to 633 exact tiling clone,   633/637
(99 %)
1 diff
(99.9 %id)
AL703150 human skeletal muscle .n 267 to 418 1 to 152       152/152
(100 %)
2 diff
(98.7 %id)
DB155464 thymus .o 1 to 586 2 to 587   tiling clone, capped   586/586
(100 %)
1 diff
(99.9 %id)
DA165157 amygdala .o 276 to 533 2 to 258   tiling clone, capped   257/258
(99 %)
2 diff
(99.3 %id)
DB084569 testis .o 477 to 1044 2 to 569   tiling clone, capped   568/568
(100 %)
0 diff
(100 %id)
BX482742   .o 640 to 1161 17 to 539       523/539
(97 %)
6 diff
(98.9 %id)
BI041958 nervous_tumor .o 834 to 1037 1 to 206       206/208
(99 %)
12 diff
(94.3 %id)
AL133016 testis .o 969 to 3323 1 to 2355 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 2355/2355
(100 %)
3 diff
(99.9 %id)
AA354408   .o 977 to 1266 1 to 292       292/292
(100 %)
2 diff
(99.4 %id)
DA535875 heart .o 1314 to 1878 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
R82700 placenta .o 1365 to 1653 7 to 299   fully sequenced,   293/299
(97 %)
5 diff
(98.4 %id)
CD513064 brain, Pituitary .o 1509 to 2237 1 to 731       731/872
(83 %)
7 diff
(99.2 %id)
R82651 placenta .o 1623 to 1847 225 to 1   fully sequenced,   225/225
(100 %)
7 diff
(96.9 %id)
CX754540 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .p-u 1 to 694 1 to 693 exact tiling clone, Submitted on the opposite strand 693/693
(100 %)
2 diff
(99.8 %id)
BY796364 eye .p-u 431 to 980 1 to 550   tiling clone,   550/550
(100 %)
1 diff
(99.9 %id)
AW630969 2 pooled high-grade transitional celltumors, genitourinary tract .p-u 505 to 851 1 to 347       347/347
(100 %)
5 diff
(98.6 %id)
AW627676 2 pooled high-grade transitional celltumors, genitourinary tract .p-u 1439 to 1798 361 to 2   tiling clone,   360/361
(99 %)
0 diff
(100 %id)
AK001030 whole embryo, mainly head .q-u 1 to 1638 2 to 1640 exact tiling clone, available from FLJ,   1640/1640
(100 %)
5 diff
(99.7 %id)
AU118455 whole embryo, mainly head .q-u 1 to 771 2 to 771 exact capped   770/770
(100 %)
6 diff
(99.3 %id)
AU145011 whole embryo, mainly head .q-u 1183 to 1638 454 to 1       454/454
(100 %)
11 diff
(97.6 %id)
DA204613 brain .q-u 1197 to 1531 2 to 336   tiling clone, capped   335/335
(100 %)
6 diff
(98.3 %id)
DC421410 uterus .r 1 to 583 1 to 584   tiling clone,   584/584
(100 %)
3 diff
(99.5 %id)
DC423772 uterus .r 5 to 564 1 to 560       560/560
(100 %)
0 diff
(100 %id)
DC296123 synovial membrane tissue from rheumatioidarthritis .r 16 to 573 1 to 558       558/558
(100 %)
0 diff
(100 %id)
DC315522 amygdala .r 32 to 599 1 to 568 exact tiling clone,   568/568
(100 %)
0 diff
(100 %id)
DA456946 tongue, tumor tissue .s 1 to 579 2 to 580 exact tiling clone, capped   579/579
(100 %)
0 diff
(100 %id)
DA858884 placenta .t 1 to 570 2 to 571 exact tiling clone, capped   570/570
(100 %)
1 diff
(99.9 %id)
DA457818 tongue, tumor tissue .u 1 to 570 2 to 571 exact tiling clone, capped   570/570
(100 %)
1 diff
(99.9 %id)
DA458867 tongue, tumor tissue .va 1 to 569 2 to 570 exact tiling clone, capped   569/569
(100 %)
0 diff
(100 %id)
DA648362   .vb 1 to 555 2 to 556 exact tiling clone, capped   555/555
(100 %)
0 diff
(100 %id)
DB254474 uterus .vc 1 to 504 2 to 505   tiling clone, capped   504/507
(99 %)
3 diff
(99.5 %id)
DA403923 thalamus .vc 3 to 549 2 to 549 R24X K25E H26A E27R L28A ... tiling clone, capped   548/548
(100 %)
1 diff
(99.9 %id)
77 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p-u, .q-u, .r, .s, .t, .u, .va, .vb, .vc Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI